Tandem Therapeutics AG
PrivateLast Round
Grant
Jun 19, 2024
Total Funding Raised
$1.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tandem Therapeutics AG is a biotechnology company that develops peptide drug conjugates to precision-target the extracellular matrix for the treatment of fibrotic diseases and fibrotic cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tandem Therapeutics AG Comparables
Compare Tandem Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Matrisome Bio | 80% | |
| Apmonia Therapeutics | 78% | |
| Engitix Therapeutics | 76% |
Tandem Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 19, 2024 | ||||
| Grant | Sep 1, 2023 | ||||
| Convertible Debt | Feb 24, 2023 |
Tandem Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| W.A. de Vigier Foundation | Grant |
| Innosuisse | Grant |
| Venture Kick | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 61% MoM.
- Sep 23, 2024
Grew 150% QoQ, from 2 to 5 employees.
Tandem Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tandem Therapeutics AG's valuation, stock price, and market status.
Is Tandem Therapeutics AG a public or private company?
Tandem Therapeutics AG is a private company.
What is the current stock price of Tandem Therapeutics AG?
Tandem Therapeutics AG is a private company with no public stock price. No recent secondary market data is available.
How much is Tandem Therapeutics AG worth (valuation)?
Valuation information for Tandem Therapeutics AG is not publicly available.
Can I buy Tandem Therapeutics AG stock?
Tandem Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tandem Therapeutics AG's last funding round?
Tandem Therapeutics AG's most recent funding round was Grant on June 19, 2024.
Who are the main investors in Tandem Therapeutics AG?
Key investors in Tandem Therapeutics AG include W.A. de Vigier Foundation, Innosuisse, Venture Kick.
Will Tandem Therapeutics AG IPO soon?
No public IPO plans have been announced for Tandem Therapeutics AG.
How can I track Tandem Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tandem Therapeutics AG's secondary market activity and sign up for updates.